1. Home
  2. STN vs VTRS Comparison

STN vs VTRS Comparison

Compare STN & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STN
  • VTRS
  • Stock Information
  • Founded
  • STN 1954
  • VTRS 1961
  • Country
  • STN Canada
  • VTRS United States
  • Employees
  • STN N/A
  • VTRS N/A
  • Industry
  • STN Military/Government/Technical
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • STN Consumer Discretionary
  • VTRS Health Care
  • Exchange
  • STN Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • STN 12.6B
  • VTRS 11.8B
  • IPO Year
  • STN N/A
  • VTRS N/A
  • Fundamental
  • Price
  • STN $110.86
  • VTRS $10.65
  • Analyst Decision
  • STN
  • VTRS Hold
  • Analyst Count
  • STN 0
  • VTRS 5
  • Target Price
  • STN N/A
  • VTRS $10.40
  • AVG Volume (30 Days)
  • STN 219.0K
  • VTRS 9.6M
  • Earning Date
  • STN 08-13-2025
  • VTRS 08-07-2025
  • Dividend Yield
  • STN 0.41%
  • VTRS 4.49%
  • EPS Growth
  • STN 29.73
  • VTRS N/A
  • EPS
  • STN 2.80
  • VTRS N/A
  • Revenue
  • STN $4,511,386,797.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • STN $13.34
  • VTRS N/A
  • Revenue Next Year
  • STN $9.72
  • VTRS $1.85
  • P/E Ratio
  • STN $39.46
  • VTRS N/A
  • Revenue Growth
  • STN 13.47
  • VTRS N/A
  • 52 Week Low
  • STN $73.18
  • VTRS $6.85
  • 52 Week High
  • STN $113.50
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • STN 58.04
  • VTRS 71.38
  • Support Level
  • STN $105.82
  • VTRS $10.55
  • Resistance Level
  • STN $108.07
  • VTRS $10.82
  • Average True Range (ATR)
  • STN 2.28
  • VTRS 0.31
  • MACD
  • STN -0.03
  • VTRS 0.09
  • Stochastic Oscillator
  • STN 91.04
  • VTRS 91.83

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: